The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment

Gynecologic Oncology

Volumn 107, Issue 1 SUPPL., 2007, Pages

  Ronco, Guglielmo ^a   Brezzi, Silvia ^b   Carozzi, Francesca ^c   Dalla Palma, Paolo ^d   Giorgi Rossi, Paolo ^e   Minucci, Daria ^f   Naldoni, Carlo ^g   Segnan, Nereo ^a   Zappa, Marco ^c   Zorzi, Manuel ^f   Cuzick, Jack ^h  

^a Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica   (Italy)

^b Viterbo cervical screening program   (Italy)

^c CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^d SANTA CHIARA HOSPITAL   (Italy)

^e Agenzia di Sanita Pubblica della Regione Lazio   (Italy)

^f VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^g Regione Emilia Romagna   (Italy)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cervical cancer; Cytology; HPV; RCT; Screening

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; EXPERIMENTAL STUDY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 34748818225     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.07.021     Document Type: Article

References (19)

1. IARC Working Group on the Evaluation of Cancer Preventive Strategies. Cervix cancer screening. IARC handbooks of cancer prevention vol. 10 (2005), IARC, Lyon
2. Cuzick J., Szarewski A., Terry G., Ho L., Hanby A., Maddox P., et al. Human papillomavirus testing in primary cervical screening. Lancet 345 (1995) 1533-1536
3. Clavel C., Masure M., Bory J.P., Putaud I., Mangeonjean C., Lorenzato, et al. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer 80 (1999) 1306-1311
4. Cuzick J., Beverley E., Ho L., Terry G., Sapper H., Mielzynska I., et al. HPV testing in primary screening of older women. Br J Cancer 81 (1999) 554-558
5. Clavel C., Masure M., Bory J.P., Putaud I., Mangeonjean C., Lorenzato M., et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 84 (2001) 1616-1623
6. Ratnam S., Franco E.L., and Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomark Prev 9 (2000) 945-951
7. Kuhn L., Denny L., Pollack A., Lorincz A., Richart R.M., and Wright T.C. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 17 92 (2000) 818-825
8. Schiffman M., Herrero R., Hildesheim A., Sherman M.E., Bratti M., Wacholder S., et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 283 (2000) 87-93
9. Schneider A., Hoyer H., Lotz B., Leistritza S., Kuhne-Heid R., Nindl I., et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 89 (2000) 529-534
10. Denny L., Kuhn L., Pollack A., Wainwright H., and Wright T.C. Evaluation of alternative methods of cervical cancer screening for resource poor settings. Cancer 89 (2000) 826-833
11. Kulasingam S.L., Hughes J.P., Kiviat N.B., Mao C., Weiss N.S., Kuypers J.M., et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 288 (2002) 1749-1757
12. Cuzick J., Szarewski A., Cubie H., Hulman G., Kitchener H., Luesley D., et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 362 (2003) 1871-1876
13. Petry K.U., Menton S., Menton M., van Loenen-Frosch F., de Carvalho Gomes H., Holz B., et al. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer 88 (2003) 1570-1577
14. Salmeron J., Lazcano-Ponce E., Lorincz A., Hernandez M., Hernandez P., Leyva A., et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 14 (2003) 505-512
15. Ronco G., Segnan N., Giorgi-Rossi P., Zappa M., Casadei G.P., Carozzi F., et al. Human papillomavirus testing and liquid-based cytology: results at recruitment from the New Technologies for Cervical Cancer randomized controlled trial. J Natl Cancer Inst 98 (2006) 765-774
16. Ronco G., Giorgi-Rossi P., Carozzi F., Dalla Palma P., Del Mistro A., De Marco L., et al. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol 7 (2006) 547-555
17. Carozzi F., De Marco L., Gillio Tos A., Girlando S., Dalla Palma P., Pellegrini A., et al. Reproducibility of HPV DNA testing by Hybrid Capture 2 in a screening setting: Intralaboratory and Interlaboratory quality control in seven laboratories participating in the same Clinical Trial. Am J Clin Pathol 124 (2005) 1-6
18. ALTS group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 92 (2000) 397-402
19. Ronco G., Cuzick J., Segnan N., Brezzi S., Carozzi F., Folicaldi S., et al. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur J Cancer 43 (2007) 476-480